Interstitial Lung Abnormalities Linked to Heart Disease

Interstitial Lung Abnormalities Linked to Heart Disease

Interstitial lung abnormalities (ILA) are increasingly common findings during routine computed tomography (CT) screenings. These early lung changes might signal future respiratory issues. However, recent evidence suggests that these findings also indicate serious cardiovascular risks. Specifically, clinicians have observed a strong link between these lung changes and coronary artery calcification (CAC).

Researchers recently analyzed data from over 2,000 individuals in the Korean National Lung Cancer Screening Program. They found that participants with interstitial lung abnormalities had a significantly higher prevalence of coronary artery calcification. About 74.7% of those with ILA exhibited some form of calcification. In contrast, only 48.1% of participants without these lung abnormalities showed similar heart-related signs. This suggests that the two conditions share underlying risk factors or pathophysiological pathways.

Impact of Interstitial Lung Abnormalities on CAC

The study also highlighted the severity of these conditions. Individuals with subpleural fibrotic or non-fibrotic lung abnormalities often displayed moderate to severe calcification. Consequently, these patients faced a higher risk of major adverse cardiovascular events (MACE). Therefore, detecting these incidental findings provides a vital opportunity for heart health intervention. Clinicians should prioritize cardiovascular assessments when they identify these abnormalities.

Cardiovascular Outcomes and Screening Benefits

Cardiovascular disease remains a leading cause of death among individuals eligible for lung cancer screening. Furthermore, the presence of severe calcification independently predicts future heart attacks and strokes. Integrating heart risk assessments into lung screening programs could improve long-term patient outcomes. Moreover, this approach allows for early treatment of atherosclerosis. Ultimately, a holistic view of screening results benefits the patient significantly.

Frequently Asked Questions

Q1: How do interstitial lung abnormalities affect cardiovascular risk?

These abnormalities are associated with a higher prevalence and severity of coronary artery calcification, which significantly increases the risk of major adverse cardiovascular events like heart attacks.

Q2: What should clinicians do if they find these abnormalities during a screening?

Clinicians should consider a comprehensive cardiovascular risk assessment and potentially initiate preventive measures for heart disease in these patients, especially if calcification is moderate or severe.

References

1. Kim YN et al. Clinical implications of coronary artery calcification in lung cancer screening populations with interstitial lung abnormalities: a retrospective cohort study. Eur Radiol. 2026 Apr 30. doi: 10.1007/s00330-026-12589-2. PMID: 42059964.
2. Putman RK et al. Interstitial Lung Abnormalities, Coronary Heart Disease, and Mortality. Eur Respir J. 2025;65(5):220286. doi: 10.1183/13993003.02286-2024.
3. Chae KJ et al. Prognostic importance of extensive coronary calcium on lung cancer screening chest computed tomography. CMAJ. 2024;196(41):E1428-E1436. doi: 10.1503/cmaj.240561.